Covid-19: Malaysia among nations excluded from global Remdesivir deal, says Dr Noor Hisham
Thursday, 21 May 2020 06:06 PM MYTThe Health Ministry revealed that Malaysia has been excluded from a voluntary licencing deal to receive Remdesivir, the drug now undergoing clinical trials as a possible Covid-19 treatment. — Ulrich Perrey/Pool pic via Reuters
PUTRAJAYA, May 21 — Malaysia has been excluded from a voluntary licencing deal to receive Remdesivir, the drug now undergoing clinical trials as a possible Covid-19 treatment, the Ministry of Health revealed today. Malaysia was among the countries excluded from the non-exclusive voluntary licencing agreement to manufacture and distribute Remdesivir to 127 nations, Health director-general Datuk Dr Noor Hisham Abdullah said during the ministry’s daily Covid-19 briefing here.
The drug’s manufacturer, Gilead Sciences, recently signed an agreement with five companies in India and Pakistan to manufacture a generic version of the antiviral drug. While the drug has yet to be tested for safety, the US Food and Drug Administration has issued emergency use authorisation for Remdesivir in hospitals for coronavirus, after preliminary trial results indicated that the medicine could successfully treat serious Covid-19 cases, online magazine Codeblue reported yesterday citing a STAT report.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
No Kawasaki cases amongst children with Covid-19 in Malaysia | New Straits TimesPUTRAJAYA: No Kawasaki cases have been detected among children infected by Covid-19 in the country, said Health director-general Datuk Dr Noor Hisham Abdullah.
Read more »
Malaysia, Singapura komited kongsi pengetahuan harungi Covid-19 | The Malaysian InsightKedua-dua negara juga komited terhadap usaha perkukuh hubugan dua hala.
Read more »
Finance minister: Malaysia, Singapore to weather Covid-19 storm together | Malay MailSINGAPORE, May 20 — Malaysia and Singapore will continue to share knowledge and experience in the battle against the Covid-19 pandemic, and will remain committed to strengthening their longstanding and multi-faceted bilateral relationship. “Tough times shall be endured together, stronger,”...
Read more »
48% jangkitan Covid-19 Malaysia adalah dari kluster tabligh, kata KP Kesihatan | The Malaysian InsightSebanyak 3,347 kes adalah daripada kluster berkenaan, berbanding 2,375 yang diumumkan sebelum ini.
Read more »
Tangani Covid-19, Malaysia di landasan yang betul, kata KP kesihatan | The Malaysian InsightKKM berharap Malaysia dapat mengekalkan angka dua digit kes baharu positif Covid-19.
Read more »